Elon Musk’s brain-computer interface startup, Neuralink, recently announced that it had received approval from the Food and Drug Administration (FDA) to conduct its first in-human clinical study. The company highlighted the milestone in a post on its official Twitter account.  As noted by Neuralink, the FDA permission is the culmination of the work that the … Continue reading Neuralink secures FDA approval for first human brain-computer interface trial